Development of Allogeneic Stem Cell-Based Platform for Delivery and Potentiation of Oncolytic Virotherapy

SIMPLE SUMMARY: The therapeutic potential of the oncolytic virotherapy is severely restricted by multiple innate and adaptive immune barriers. Here, we describe how the Supernova (SNV) cell-based oncolytic platform can be utilized to generate off-the-shelf products for cancer treatments. CAL1 vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Duong Hoang, Herrmann, Thomas, Härtl, Barbara, Draganov, Dobrin, Minev, Ivelina, Neuharth, Forrest, Gomez, Alberto, Alamillo, Ashley, Schneider, Laura Edith, Kleinholz, Daniela, Minev, Boris, Santidrian, Antonio F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777144/
https://www.ncbi.nlm.nih.gov/pubmed/36551636
http://dx.doi.org/10.3390/cancers14246136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777144/
https://www.ncbi.nlm.nih.gov/pubmed/36551636
http://dx.doi.org/10.3390/cancers14246136

Ejemplares similares